EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

HIV-Associated Nephropathy in 2022

Frederick Berro Rivera, Marie Francesca Mapua Ansay, Jem Marie Golbin, Pia Gabrielle I Alfonso, Gerard Francis E Mangubat, Rajiv Hans Solita Menghrajani, Siena Placino, Marianne Katharina Vicera Taliño, Deogracias Villa De Luna, Nicolo Cabrera, Carlo Nemesio Trinidad, Amir Kazory

Glomerular Diseases · 24.10.2022 · 3 (1) · 1-11

DOI: 10.1159/000526868 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Glomerular Diseases, online erschienen am 24.10.2022. Verfasst von Frederick Berro Rivera und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Lincoln Medical Center, New York, New York, USA. Die Arbeit wurde bisher 27-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background: HIV-associated nephropathy (HIVAN) is a renal parenchymal disease that occurs exclusively in people living with HIV. It is a serious kidney condition that may possibly lead to end-stage kidney disease, particularly in the HIV-1 seropositive patients. Summary: The African-American population has increased susceptibility to this comorbidity due to a strong association found in the APOL1 gene, specifically two missense mutations in the G1 allele and a frameshift deletion in the G2 allele, although a “second-hit” event is postulated to have a role in the development of HIVAN. HIVAN presents with proteinuria, particularly in the nephrotic range, as with other kidney diseases. The diagnosis requires biopsy and typically presents with collapsing subtype focal segmental glomerulosclerosis and microcyst formation in the tubulointerstitial region. Gaps still exist in the definitive treatment of HIVAN – concurrent use of antiretroviral therapy and adjunctive management with like renal-angiotensin-aldosterone system inhibitors, steroids, or renal replacement therapy showed benefits. Key Message: This study reviews the current understanding of HIVAN including its epidemiology, mechanism of disease, related genetic factors, clinical profile, and pathophysiologic effects of management options for patients.

Schlagwörter

Stichwörter der Autor:innen

Chronic kidney diseaseGlomerular diseaseGlomerulonephritisHIV-associated nephropathyPathology

Autor:innen und Institutionen

  • Department of Medicine, Lincoln Medical Center, New York, New York, USA.
  • Ateneo de Manila School of Medicine and Public Health, Pasig, Philippines.
  • University of the Philippines System, Manila, Philippines.
  • Department of Medicine, Southern Philippines Medical Center, Davao City, Philippines.
  • St. Luke's Medical Center College of Medicine - William H. Quasha Memorial, Quezon City, Philippines.
  • Department of Internal Medicine, Danbury Hospital, Danbury, Connecticut, USA.

Zitieren

APA

Rivera, F. B., Ansay, M. F. M., Golbin, J. M., Alfonso, P. G. I., Mangubat, G. F. E., Menghrajani, R. H. S., Placino, S., Taliño, M. K. V., De Luna, D. V., Cabrera, N., Trinidad, C. N., & Kazory, A. (2022). HIV-Associated Nephropathy in 2022. Glomerular Diseases, 3(1), 1-11. https://doi.org/10.1159/000526868

Vancouver

Rivera FB, Ansay MFM, Golbin JM, Alfonso PGI, Mangubat GFE, Menghrajani RHS, et al. HIV-Associated Nephropathy in 2022. Glomerular Diseases. 2022;3(1):1-11. doi:10.1159/000526868

BibTeX
@article{Rivera2022,
  author = {Rivera, Frederick Berro and Ansay, Marie Francesca Mapua and Golbin, Jem Marie and Alfonso, Pia Gabrielle I and Mangubat, Gerard Francis E and Menghrajani, Rajiv Hans Solita and Placino, Siena and Taliño, Marianne Katharina Vicera and De Luna, Deogracias Villa and Cabrera, Nicolo and Trinidad, Carlo Nemesio and Kazory, Amir},
  title = {HIV-Associated Nephropathy in 2022},
  journal = {Glomerular Diseases},
  year = {2022},
  volume = {3},
  number = {1},
  pages = {1--11},
  doi = {10.1159/000526868}
}
Kostenlos starten →